ICD-11 · 6C46.22

Stimulant dependence including amphetamines, methamphetamine or methcathinone, sustained partial remission

After a diagnosis of Stimulant dependence including amphetamines, methamphetamine and methcathinone but excluding caffeine, cocaine and synthetic cathinones, and often following a treatment episode or other intervention (including self-help intervention), there is a significant reduction in amphetamine or other stimulant consumption for more than 12 months, such that even though amphetamine or other stimulant use has occurred during this period, the definitional requirements for dependence have not been met.

Differential diagnosis

When diagnosing Stimulant dependence including amphetamines, methamphetamine or methcathinone, sustained partial remission, the following ICD-11 disorders should be considered in the differential diagnosis:

Frequently asked questions

What disorders are in the differential diagnosis of Stimulant dependence including amphetamines, methamphetamine or methcathinone, sustained partial remission?

The differential diagnosis of Stimulant dependence including amphetamines, methamphetamine or methcathinone, sustained partial remission (6C46.22) includes: Epizod szkodliwego używania środków pobudzających, w tym amfetaminy, metamfetaminy lub metylkatynonu (6C46.0), Szkodliwy wzorzec używania środków pobudzających, w tym amfetamin, metamfetaminy lub metylkatynonu (6C46.1).

WHO ICD-11 source

View this entry in the official WHO ICD-11 browser: 6C46.22 – WHO ICD-11

Open in interactive browser →
Source: WHO ICD-11 (chapter 6 – Mental, behavioral and neurodevelopmental disorders). Used under CC BY-ND 3.0 IGO. ICD Diagnostica is not affiliated with or endorsed by WHO. Informational use only – does not replace clinical judgment.